[1]贺琼 薄佳琪 张梦圆 王维 何传辉 刘云峰.骨膜蛋白在糖尿病心肌病发病中的作用[J].国际内分泌代谢杂志,2020,40(04):271-274.[doi:10.3760/cma.j.issn.1673-4157.2020.04.013]
　He Qiong,Bo Jiaqi,ZhangMengyuan,et al.Role of periostin in the pathogenesis of diabetic cardiomyopathy[J].International Journal of Endocrinology and Metabolism,2020,40(04):271-274.[doi:10.3760/cma.j.issn.1673-4157.2020.04.013]
点击复制

骨膜蛋白在糖尿病心肌病发病中的作用
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
40
期数:
2020年04期
页码:
271-274
栏目:
基础研究
出版日期:
2020-07-20

文章信息/Info

Title:
Role of periostin in the pathogenesis of diabetic cardiomyopathy
作者:
贺琼1; 2 薄佳琪1 张梦圆1 王维1 何传辉1 刘云峰2
1山西医科大学,太原 030001; 2山西医科大学第一医院内分泌科,太原 030001
Author(s):
He Qiong1; 2;  Bo Jiaqi1;  ZhangMengyuan1;  Wang Wei1;  He Chuanhui1;  Liu Yunfeng2
1Shanxi Medical University, Taiyuan 030001, China; 2Department of Endocrinology, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
关键词:
骨膜蛋白;  糖尿病心肌病;  信号通路
Keywords:
Periosteal protein;  Diabetic cardiomyopathy;  Signaling pathways
DOI:
10.3760/cma.j.issn.1673-4157.2020.04.013
摘要:
造成糖尿病心肌病(DCM)代谢异常的主要机制有高糖血症、脂代谢紊乱、胰岛素抵抗、肾素-血管紧张素-醛固酮系统(RAAS)激活等。近期研究证实,骨膜蛋白在脂代谢紊乱发生、胰岛素抵抗形成、RAAS的激活中均发挥一定作用,从而加速了DCM的形成和发展。此外,在DCM发病早期即可检测出骨膜蛋白的表达,且随着疾病进展,骨膜蛋白表达含量增加。据此推测,骨膜蛋白可能对DCM的发病及其严重程度均有一定程度的预测价值,具有研发成为DCM早期分子诊断标志物的潜质。
Abstract:
The main mechanisms that cause the abnormal metabolism of diabetic cardiomyopathy(DCM)are hyperglycemia, lipid metabolism disorder, insulin resistance, renin-angiotensin-aldosterone system(RAAS)activation and so on. Recent studies have confirmed that periosteal proteins play a role in the occurrence of lipid metabolism disorders, the formation of insulin resistance, and the activation of RAAS, thereby accelerating the formation and development of DCM. In addition, the expression of periosteal protein can be detected early in the onset of DCM, and as the disease progresses, the expression of periosteal protein content increases. Based on this, it is speculated that periosteal protein may have a certain degree of predictive value for the incidence and severity of DCM, and has the potential to be developed as an early molecular diagnostic marker of DCM.

参考文献/References:

[1] Lee WS, Kim J. Diabetic cardiomyopathy: where we are and where we are going [J]. Korean J Intern Med,2017,32(3):404-421.DOI:10.3904/kjim.2016.208.
[2] Caravaggi P, Giangrande A, Lullini G, et al. In shoe pressure measurements during different motor tasks while wearing safety shoes:the effect of custom made insoles vs. prefabricated and off-the-shelf [J]. Gait Posture,2016,50:232-238.DOI:10.1016/j.gaitpost.2016.09.013.
[3] Lavery LA, Vela SA, Lavery DC, et al. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments [J]. Diabetes Care,1996,19(8):818-821.DOI:10.2337/diacare.19.8.818.
[4] DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity [J]. Nat Rev Endocrinol,2014,10(6):364-376.DOI:10.1038/nrendo.2014.44.
[5] Frangogiannis NG. Matricellular proteins in cardiac adaptation and disease [J]. Physiol Rev, 2012, 92(2):635-688.DOI: 10.1152/physrev.00008.2011.
[6] Kii I. Practical application of periostin as a biomarker for pathological conditions [J]. Adv Exp Med Biol, 2019, 1132: 195-204.DOI:10.1007/978-981-13-6657-4_18.
[7] Stansfield WE, Andersen NM, Tang RH, et al. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart [J]. Ann Thorac Surg, 2009, 88(6):1916-1921.DOI:10.1016/j.athoracsur.2009.07.038.
[8] 邹翎, 张薇薇, 宋彬,等. 糖尿病外周血管病变的MRI血管成像研究[J]. 四川大学学报(医学版), 2010, 041(3):505-508.DOI:CNKI:SUN:HXYK.0.2010-03-035.
[9] Guan J, Liu WQ, Xing MQ, et al. Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan [J]. BMC Cardiovasc Disord, 2015, 15:90.DOI:10.1186/s12872-015-0084-3.
[10] Wu H, Li GN, Xie J, et al.Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-beta/periostin pathway in STZ-induced diabetic mice [J]. BMC Cardiovasc Disord, 2016,16:5.DOI:10.1186/s12872-015-0169-z.
[11] Luo Y, Qu H, Wang H, et al. Plasma periostin levels are increased in Chinese subjects with obesity and type 2 diabetes and are positively correlated with glucose and lipid parameters [J]. Mediators Inflamm, 2016,2016:6423637.DOI:10.1155/2016/6423637.
[12] Liu GX, Hanley PJ, Ray J,et al. Long-chain acyl-coenzyme aesters and fatty acids directly link metabolism to KATP channels in the heart [J].Circ Res,2001,88(9):918-924.DOI:10.1161/hh0901.089881.
[13] Burkart EM, Sambandam N, Han X, et al. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart [J]. 2007,117(12):3930-3939. DOI:10.1172/JCI32578.
[14] Ritchie RH, Zerenturk EJ, Prakoso D, et al. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy[J]. J Mol Endocrinol,2017,58(4):R225-R240. DOI:10.1530/JME-16-0249.
[15] Lu Y, Liu X, Jiao Y, et al. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα [J].J Clin Invest,2014,124(8):3501-3513.DOI:10.1172/JCI74438.
[16] Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance [J]. Nature,2002,420(6913):333-336.DOI:10.1038/nature01137.
[17] Nakazeki F, Nishiga M, Horie T, et al. Loss of periostin ameliorates adipose tissue inflammation and fibrosis in vivo[J]. Sci Rep,2018,8(1):8553.DOI:10.1038/s41598-018-27009-9.
[18] Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy [J].Nat Rev Endocrinol,2016,12(3):144-153.DOI:10.1038/nrendo.2015.216.
[19] Kim JA, Jang HJ, Martinez-Lemus LA, et al. Activation of mTOR/p70S6 kinase by ANG Ⅱ inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation [J].Am J Physiol Endocrinol Metab, 2012,302(2):E201-E208.DOI:10.1152/ajpendo.00497.2011.
[20] Jia G, Habibi J, DeMarco VG, et al. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females [J].Hypertension, 2015, 66(6):1159-1167.DOI:10.1161/HYPERTENSIONAHA.115.06015.
[21] Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease [J]. Diabetologia, 2018, 61(1):21-28.DOI:10.1007/s00125-017-4390-4.
[22] Shen JZ, Young MJ. Corticosteroids, heart failure, and hypertension:a role for immune cells?[J]. Endocrinology, 2012, 153(12):5692-5700.DOI:10.1210/en.2012-1780.
[23] Li L, Fan D, Wang C, et al. Angiotensin Ⅱ increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-beta1 pathways in cardiac fibroblasts [J].Cardiovasc Res, 2011,91(1):80-89.DOI:10.1093/cvr/cvr067.
[24] Li Q, Liu X, Wei J. Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent [J]. Biochem Biophys Res Commun,2014,452(3):497-502.DOI:10.1016/j.bbrc.2014.08.109.
[25] Chen T, Li M, Fan X,et al. Sodium tanshinone Ⅱ A sulfonate prevents angiotensin Ⅱ-induced differentiation of human atrial fibroblasts into myofibroblasts [J]. Oxid Med Cell Longev, 2018, 2018.DOI:10.1155/2018/6712585.
[26] Kuo HF, Hsieh CC, Wang SC, et al. Simvastatin attenuates cardiac fibrosis via regulation of cardiomyocyte-derived exosome secretion [J]. J Clin Med, 2019, 8(6):794.DOI:10.3390/jcm8060794.

相似文献/References:

[1]林延艳,赵林双.运动改善糖尿病心肌病的机制[J].国际内分泌代谢杂志,2017,37(03):207.[doi:10.3760/cma.j.issn.1673-4157.2017.03.017]
　Lin Yanyan,Zhao Linshuang..Mechanisms of exercise in improving diabetic cardiomyopathy[J].International Journal of Endocrinology and Metabolism,2017,37(04):207.[doi:10.3760/cma.j.issn.1673-4157.2017.03.017]
[2]罗俊婷 胡欣 陈国芳 刘超.骨膜蛋白与代谢性疾病[J].国际内分泌代谢杂志,2018,38(01):26.[doi:10.3760/cma.j.issn.1673-4157.2018.01.007]
　Luo Junting,Hu Xin,Chen Guofang,et al.Periostin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(04):26.[doi:10.3760/cma.j.issn.1673-4157.2018.01.007]
[3]钟祯 张霄旦 李万根.内质网与线粒体相互作用在糖尿病心肌病中的作用[J].国际内分泌代谢杂志,2019,39(01):57.[doi:10.3760/cma.j.issn.1673-4157.2019.01.014]
　Zhong Zhen,Zhang Xiaodan,Li Wangen.Roles of the interactions between endoplasmic reticulum and mitochondria in diabetic cardiomyopathy[J].International Journal of Endocrinology and Metabolism,2019,39(04):57.[doi:10.3760/cma.j.issn.1673-4157.2019.01.014]
[4]张坦 杨洋.三维斑点追踪成像技术在评估糖尿病心肌病中的作用[J].国际内分泌代谢杂志,2019,39(05):319.[doi:10.3760/cma.j.issn.1673-4157.2019.05.008]
　Zhang Tan,Yang Yang.Effect of three dimensional speckle tracking imaging technology in the assessment of diabetic cardiomyopathy[J].International Journal of Endocrinology and Metabolism,2019,39(04):319.[doi:10.3760/cma.j.issn.1673-4157.2019.05.008]

备注/Memo

备注/Memo:
通信作者:刘云峰,Email:nectarliu@163.com
Corresponding author: Liu Yunfeng, Email: nectarliu@163.com
Fund program:National Natural Science Foundation of China(81770776); Graduate Education Innovation Project of Shanxi Province(258); Key Research and Development Project of Shanxi Province(201903D321127)
更新日期/Last Update: 2020-07-20